Kymera Therapeutics
Focus: Kymera Therapeutics is a clinical-stage biotech focused on targeted protein degradation using small molecules to treat immunology, respiratory, and oncology indications. The company operates from its Watertown, MA headquarters with an active pipeline spanning Phase 1–2 trials.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
25+2 this month
Stable — net +2 jobs in 30d
11 added, 9 removed. Backfill posture.
Should You Work at Kymera Therapeutics?
AI assessmentAttractive for early-career scientists and platform technologists seeking high-risk/high-reward exposure to a novel degradation modality, but unsuitable for professionals requiring near-term commercial-stage activity or revenue stability.
Why Work Here
- Emerging platform technology (targeted protein degradation) in early clinical validation with multiple Phase 2 programs in high-value indications like atopic dermatitis and eosinophilic asthma.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
13 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atop
Hidradenitis SuppurativaClinical Trials (1)
NCT04440410Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis
N/AHelp build intelligence for Kymera Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.